Current issue
Journal content
Articles in press
Archive
About the Journal
About the Polish Annals of Medicine
Editorial Board
Abstracting & indexing
Open Access policy
Charges
Affiliated institutions
Contact
Instructions
Peer review process
Guide for authors
Publication ethics
Ethics and Patient Consent
User License
Usage of third party materials
Disclaimer
Statement on Artificial Intelligence
Reviewers
Guide for reviewers
Review Form
REVIEW PAPER
The role of Blastocystis sp. as an etiology of irritable bowel syndrome
1
Department of Medical Biology, Faculty of Medical Sciences, University of Warmia and Mazury in Olsztyn, Poland
Submission date: 2014-12-08
Acceptance date: 2015-04-01
Online publication date: 2015-04-20
Publication date: 2020-03-23
Corresponding author
Małgorzata Lepczyńska
Żołnierska 14C/ 14, 10-561 Olsztyn, Poland. Tel.: +48 89 524 61 16; fax: +48 89 524 61 16.
Żołnierska 14C/ 14, 10-561 Olsztyn, Poland. Tel.: +48 89 524 61 16; fax: +48 89 524 61 16.
Pol. Ann. Med. 2016;23(1):57-60
KEYWORDS
ABSTRACT
Introduction:
Blastocystis is a common intestinal protozoan of humans and animals. The role of this organism as a pathogen is still controversial. The Blastocystis infection could be asymptomatic or could include nausea, anorexia, abdominal pain, flatulence, and/or diarrhea. An association between Blastocystis infection and acute chronic digestive disorders such as irritable bowel syndrome (IBS) have also been suggested.
Aim:
In this article, the evidence concerning Blastocystis infection causing IBS will be discussed, with regard to the subtypes of the parasite.
Discussion:
An association between the parasite and IBS has been suggested in the recent literature. The explanations of pathogenicity include an intra-subtype difference (ST4 and ST7) with regard to protease activity during infection with Blastocystis.
Conclusions:
It is most likely that the presence of Blastocystis in the human intestine plays a significant role in IBS. On the other hand, it is still not known if Blastocystis is the etiological agent responsible for this type of gut dysfunction. There are many reports in the literature which are mutually exclusive. More studies are needed to confirm this hypothesis.
Blastocystis is a common intestinal protozoan of humans and animals. The role of this organism as a pathogen is still controversial. The Blastocystis infection could be asymptomatic or could include nausea, anorexia, abdominal pain, flatulence, and/or diarrhea. An association between Blastocystis infection and acute chronic digestive disorders such as irritable bowel syndrome (IBS) have also been suggested.
Aim:
In this article, the evidence concerning Blastocystis infection causing IBS will be discussed, with regard to the subtypes of the parasite.
Discussion:
An association between the parasite and IBS has been suggested in the recent literature. The explanations of pathogenicity include an intra-subtype difference (ST4 and ST7) with regard to protease activity during infection with Blastocystis.
Conclusions:
It is most likely that the presence of Blastocystis in the human intestine plays a significant role in IBS. On the other hand, it is still not known if Blastocystis is the etiological agent responsible for this type of gut dysfunction. There are many reports in the literature which are mutually exclusive. More studies are needed to confirm this hypothesis.
CONFLICT OF INTEREST
None declared.
REFERENCES (48)
1.
Tan KS. New insights on classification, identification and clinical relevance of Blastocystis spp. Clin Microbiol Rev. 2008;21(4):639–665.
2.
Bálint A, Dóczi I, Bereczki L, et al. Do not forget the stool examination!-cutaneous and gastrointestinal manifestations of Blastocystis sp. infection. Parasitol Res. 2014;113(4):1585–1590.
3.
Doyle PW, Helgason MM, Mathias RG, Proctor EM. Epidemiology and pathogenicity of Blastocystis hominis. J Clin Microbiol. 1990;28(1):116–121.
4.
Lu CTL, Sung YJ. Epidemiology of Blastocystis hominis and other intestinal parasites among the immigrant population in northeastern Taiwan by routine physical examination for resistance approval. J Microbiol Immunol Infect. 2009;42(6):505–509.
5.
Zaglool DAM, Khodari YAW, Farooq MU. Blastocystis hominis and allergic skin diseases; a single centre experience. J Health Sci. 2012;2(1):66–69.
6.
Sanchez-Aguillon F, Lopez-Escamilla E, Velez-Perez F, et al. Parasitic infections in a Mexican HIV/AIDS cohort. J Infect Dev Ctries. 2013;7(10):763–766.
7.
Basak S, Rajurkar MN, Mallick SK. Detection of Blastocystis hominis: a controversial human pathogen. Parasitol Res. 2014;113(1):261–265.
8.
Roberts T, Stark D, Harkness J, Ellis J. Update on the pathogenic potential and treatment options for Blastocystis sp.. Gut Pathogens. 2012;6:17–25.
9.
Silberman JD, Sogin ML, Leipe DD, Clark CG. Human parasite finds taxonomic home. Nature. 1996;380(6573):398.
10.
Parija SC, Jeremiah SS. Blastocystis: taxonomy, biology and virulence. Trop Parasitol. 2013;3(1):17–25.
11.
Lee LI, Chye TT, Karmacharya BM, Govind SK. Blastocystis sp.: waterborne zoonotic organism, a possibility? Parasites Vectors. 2012;5:130–134.
12.
Alfellani MA, Taner-Mulla D, Jacob AS, et al. Genetic diversity of Blastocystis in Livestock and Zoo animals. Protist. 2013;164(4):497–509.
13.
Stensvold CR, Alfellani M, Clark CG. Levels of genetic diversity vary dramatically between Blastocystis subtypes. Infect Genet Evol. 2012;12(2):263–273.
14.
Alfellani MA, Stensvold CR, Vidal-Lapiedra A, Onuoha ES, Faqbenro-Beyioku AF, Clark CG. Variable geographic distribution of Blastocystis subtypes and its potential implications. Acta Trop. 2013;126(1):11–18.
15.
Stensvold CR, Suresh GK, Tan KS, et al. Terminology for Blastocystis subtypes – a consensus. Trends Parasitol. 2007;23(3):93–96.
16.
Scicluna SM, Tawari B, Clark CG. DNA barcoding of Blastocystis. Protist. 2006;157(1):77–85.
17.
Fayer R, Elsasser T, Gould R, Solano G, Urban Jr J, Santin M. Blastocystis tropism in the pig intestine. Parasitol Res. 2014;113(4):1465–1472.
18.
Moosavi A, Haghighi A, Mojarad EN, et al. Genetic variability of Blastocystis sp. isolated from symptomatic and asymptomatic individuals in Iran. Parasitol Res. 2012;111(6):2311–2315.
19.
Yakoob J, Jafri W, Jafri N, et al. Irritable bowel syndrome: in search of an etiology: role of Blastocystis hominis. Am J Trop Med Hyg. 2004;70(4):383–385.
20.
Katsarou-Katsari A, Vassalos CM, Tzanetou K, Spanakos G, Papadopoulou C, Vakalis N. Acute urticaria associated with amoeboid forms of Blastocystis sp. subtype 3. Acta Derm Venereol. 2007;88(1):80–81.
21.
Giacometti A, Cirioni O, Fiorentini A, Fortuna M, Scalise G. Irritable bowel syndrome in patients with Blastocystis hominis infection. Eur J Clinl Microbiol Infect Dis. 1999;18(6):436–439.
22.
Fouad SA, Basyoni MMA, Fahmy RA, Kobaisi MH. The pathogenic role of different Blastocystis hominis genotypes isolated from patients with irritable bowel syndrome. Arab J Gastroenterol. 2011;12(4):194–200.
23.
Stark D, van Hal S, Marriott D, Ellis J, Harkness J. Irritable bowel syndrome: a review on the role of intestinal protozoa and the importance of their detection and diagnosis. Int J Parasitol. 2007;37(1):11–20.
24.
Poirier P, Wawrzyniak I, Vivarès CP, Delbac F, El Alaoui H. New insights into Blastocystis spp.: a potential link with irritable bowel syndrome. PLoS Pathog. 2012;8(3):e1002545.
25.
Longstreth GF, Thompson WG, Chey WD, Houghton LA, Mearin F, Spiller RC. Functional bowel disorders. Gastroenterology. 2006;130(5):1480–1491.
26.
Spiller R, Garsed K. Infection, inflammation, and the irritable bowel syndrome. Dig Liver Dis. 2009;41(12):844–849.
27.
Rasquin-Weber A, Hyman PE, Cucchiara S, et al. Childhood functional gastrointestinal disorders. Gut. 1999;45:1160–1168.
28.
El Safadi D, Meloni D, Poirier P, et al. Molecular epidemiology of Blastocystis in Lebanon and correlation between subtype 1 and gastrointestinal symptoms. Am J Trop Med Hyg. 2013;88(6):1203–1206.
29.
Scanlan PD. Blastocystis: past pitfalls and future perspectives. Trends Parasitol. 2012;28(8):327–334.
30.
Dogruman-Al F, Simsek Z, Boorom K, et al. Comparison of methods for detection of Blastocystis infection in routinely submitted stool samples, and also in IBS/IBD patients in Ankara, Turkey. PLoS ONE. 2010;5(11):e15484. http://dx.doi.org/10.1371/jour....
31.
Udkow MP, Markell EK. Blastocystis hominis: prevalence in asymptomatic versus symptomatic hosts. J Infect Dis. 1993;168(1):242–244.
32.
Cekin AH, Cekin Y, Adakan Y, Tasdemir E, Koclar F, Yolcular B. Blastocystosis in patients with gastrointestinal symptoms: a case-control study. BMC Gastroenterol. 2012;12:122–127.
33.
Kaneda Y, Horiki N, Cheng XJ, Fujita Y, Maruyama M, Tachibana H. Ribodemes of Blastocystis hominis isolated in Japan. Am J Trop Med Hyg. 2001;65(4):393–396.
34.
Yan Y, Su S, Lai R, et al. Genetic variability of Blastocystis hominis isolates in China. Parasitol Res. 2006;99(5):597–601.
35.
Hussein EM, Hussein AM, Eida MM, Atwa MM. Pathophysiological variability of different genotypes of human Blastocystis hominis Egyptian isolates in experimentally infected rats. Parasitol Res. 2008;102(5):853–860.
36.
Stensvold CR, Christiansen DB, Olsen KE, Nielsen HV. Blastocystis sp. subtype 4 is common in Danish Blastocystispositive patients presenting with acute diarrhea. Am J Trop Med Hyg. 2011;84(6):883–885.
37.
Yakoob J, Jafri W, Beg MA, et al. Irritable bowel syndrome: is it associated with genotypes of Blastocystis hominis. Parasitol Res. 2010;106(5):1033–1038.
38.
Wawrzyniak I, Poirier P, Viscogliosi E, et al. Blastocystis, an unrecognized parasite: an overview of pathogenesis and diagnosis. Ther Adv Infect Dis. 2013;167–178. http://dx.doi.org/10.1177/2049....
39.
Abdel-Hameed DM, Hassanin OM. Protease activity of Blastocystis hominis subtype 3 in symptomatic and asymptomatic patients. Parasitol Res. 2011;109(2):321–327.
40.
Mirza H, Tan KSW. Blastocystis exhibits inter- and intrasubtype variation in cysteine protease activity. Parasitol Res. 2009;104(2):355–361.
41.
Sio SWS, Puthia MK, Lee ASY, Lu J, Tan KS. Protease activity of Blastocystis hominis. Parasitol Res. 2006;99(2):126–130.
42.
Puthia MK, Vaithilingam A, Lu J, Tan KS. Degradation of human secretory immunoglobulin A by Blastocystis. Parasitol Res. 2005;97(5):386–389.
43.
Puthia MK, Lu J, Tan KS. Blastocystis ratti contains cysteine proteases that mediate interleukin-8 response from human intestinal epithelial cells In an NF-kappaB-dependent manner. Eukaryotic cell. 2008;7(3):435–443.
44.
Wawrzyniak I, Texier C, Poirier P, et al. Characterization of two cysteine proteases secrete by Blastocystis ST7, a human intestinal parasite. Parasitol Int. 2012;61(3):437–442.
45.
Boorom KF, Smith H, Nimri L, et al. Oh my aching gut: irritable bowel syndrome, Blastocystis, and asymptomatic infection. Parasit Vectors. 2008;1:40–55.
46.
Coyle C, Varughese J, Weiss L, Tanowitz H. Blastocystis: to treat or not to treat. Clin Infect Dis. 2012;54(1):105–110.
47.
Hussain R, Jaferi W, Zuberi S, et al. Significantly increased IgG2 subclass antibody levels to Blastocystis hominis to patients with irritable bowel syndrome. Am J Trop Med Hyg. 1997;56(3):301–306.
48.
Streck N, Mueller K, Schemann M, Haller D. Bacterial proteases in IBD and IBS. Gut. 2012;61(11):1610–1618.
We process personal data collected when visiting the website. The function of obtaining information about users and their behavior is carried out by voluntarily entered information in forms and saving cookies in end devices. Data, including cookies, are used to provide services, improve the user experience and to analyze the traffic in accordance with the Privacy policy. Data are also collected and processed by Google Analytics tool (more).
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
